Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Flat Capital AB (publ) in connection with its listing on Nasdaq First North Growth Market
Mandate

Vinge has advised Flat Capital AB (publ) in connection with its listing on Nasdaq First North Growth Market

October 20, 2021 Capital Markets and Public M&A

Vinge has advised Flat Capital AB (publ) (“Flat Capital” or the “Company”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 29 September 2021 and the first day of trading on Nasdaq First North Growth Market was 20 October 2021.

Flat Capital is an investment company founded by Nina and Sebastian Siemiatkowski that focuses on companies with prominent entrepreneurs in leading positions. The company aims to contribute long-term capital to entrepreneur-led companies that may otherwise be dependent on investors with shorter time horizons. The largest investments are Klarna Holding AB, Budbee AB and True Software Scandinavia AB (Truecaller).


Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg, Anna Grigorian and Anna Svensson.

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025